Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
66.35
+10.35 (18.48%)
At close: Feb 11, 2026, 4:00 PM EST
66.63
+0.28 (0.42%)
After-hours: Feb 11, 2026, 5:14 PM EST

Nektar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,3501721084252,4933,050
Market Cap Growth
735.71%59.16%-74.63%-82.96%-18.24%-19.68%
Enterprise Value
1,196129-201791,8662,117
Last Close Price
56.0013.958.4733.90202.65255.00
PS Ratio
13.671.741.204.6124.4719.94
PB Ratio
12.932.820.821.163.672.83
P/TBV Ratio
15.272.820.821.464.143.05
EV/Sales Ratio
19.111.31-1.9418.3113.84
Debt / Equity Ratio
1.963.201.760.780.500.33
Asset Turnover
0.210.280.160.100.080.09
Inventory Turnover
--1.911.241.601.39
Quick Ratio
4.094.185.977.538.909.55
Current Ratio
4.244.266.458.019.349.83
Return on Equity (ROE)
-180.24%-124.10%-110.95%-70.39%-59.64%-35.80%
Return on Assets (ROA)
-27.98%-23.14%-15.25%-16.43%-21.00%-13.51%
Return on Invested Capital (ROIC)
--450.92%-131.09%-111.04%-137.22%-81.99%
Return on Capital Employed (ROCE)
-58.00%-53.60%-39.00%-37.40%-43.20%-26.70%
Earnings Yield
-9.29%-69.35%-256.12%-86.68%-21.01%-14.57%
FCF Yield
-14.65%-103.28%-179.50%-72.91%-17.15%-10.51%
Buyback Yield / Dilution
-14.07%-8.24%-1.53%-2.10%-2.64%-2.05%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q